Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 8c; Boosts FY15 EPS Outlook

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.64, $0.08 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.76 billion versus the consensus estimate of $1.76 billion.

Zimmer Biomet Holdings sees FY2015 EPS of $6.83-$6.87, versus prior guidance of $6.65-$6.80 and the consensus of $6.73.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• Creatd files Form S-1 and reports Q1 2026 financial results